PE20040749A1 - Piperidinas espirosustituidas como antagonistas selectivos del receptor de la hormona concentradora de melanina - Google Patents

Piperidinas espirosustituidas como antagonistas selectivos del receptor de la hormona concentradora de melanina

Info

Publication number
PE20040749A1
PE20040749A1 PE2003000647A PE2003000647A PE20040749A1 PE 20040749 A1 PE20040749 A1 PE 20040749A1 PE 2003000647 A PE2003000647 A PE 2003000647A PE 2003000647 A PE2003000647 A PE 2003000647A PE 20040749 A1 PE20040749 A1 PE 20040749A1
Authority
PE
Peru
Prior art keywords
melanin
spirosustituted
piperidins
hormone receptor
cr2r3
Prior art date
Application number
PE2003000647A
Other languages
English (en)
Spanish (es)
Inventor
Duane A Burnett
Wen-Lian Wu
Martin S Domalski
Thavalakulam K Sasikumar
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE20040749A1 publication Critical patent/PE20040749A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PE2003000647A 2002-06-27 2003-06-26 Piperidinas espirosustituidas como antagonistas selectivos del receptor de la hormona concentradora de melanina PE20040749A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39181302P 2002-06-27 2002-06-27

Publications (1)

Publication Number Publication Date
PE20040749A1 true PE20040749A1 (es) 2004-10-23

Family

ID=30000757

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000647A PE20040749A1 (es) 2002-06-27 2003-06-26 Piperidinas espirosustituidas como antagonistas selectivos del receptor de la hormona concentradora de melanina

Country Status (14)

Country Link
US (1) US7109207B2 (https=)
EP (1) EP1532147B1 (https=)
JP (1) JP4522853B2 (https=)
CN (1) CN100374440C (https=)
AR (1) AR040344A1 (https=)
AT (1) ATE334983T1 (https=)
AU (1) AU2003258957A1 (https=)
CA (1) CA2490531C (https=)
DE (1) DE60307289T2 (https=)
ES (1) ES2266861T3 (https=)
MX (1) MXPA05000185A (https=)
PE (1) PE20040749A1 (https=)
TW (1) TW200401777A (https=)
WO (1) WO2004002987A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002352878B2 (en) 2001-11-27 2007-11-22 Merck Sharp & Dohme Corp. 2-Aminoquinoline compounds
EP1595867A4 (en) 2003-02-10 2008-05-21 Banyu Pharma Co Ltd PIPERIDINE DERIVATIVES AS AN ACTIVE ANTAGONIST AT THE RECIPE OF MELANIN CONCENTRATING HORMONE
DE602004013427T2 (de) * 2003-02-28 2009-06-04 Schering Corp. Biaryltetrahydroisochinolin-piperidine als selektive mch-rezeptor-antagonisten zur behandlung von adipositas und verwandten erkrankungen
US7354925B2 (en) 2004-03-29 2008-04-08 Pfizer Inc. Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists
TW200630337A (en) * 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
WO2006104136A1 (ja) * 2005-03-29 2006-10-05 Banyu Pharmaceutical Co., Ltd. 非アルコール性脂肪性肝疾患の治療剤、及び非アルコール性脂肪性肝疾患の治療又は予防のための薬剤の候補化合物のスクリーニング方法
WO2007110449A1 (en) * 2006-03-29 2007-10-04 Euro-Celtique S.A. Benzenesulfonamide compounds and their use
WO2007118854A1 (en) * 2006-04-13 2007-10-25 Euro-Celtique S.A. Benzenesulfonamide compounds and the use thereof
US8791264B2 (en) * 2006-04-13 2014-07-29 Purdue Pharma L.P. Benzenesulfonamide compounds and their use as blockers of calcium channels
US20090247560A1 (en) * 2006-09-28 2009-10-01 Banyu Pharmaceutical Co., Ltd. Diaryl ketimine derivative
WO2008124118A1 (en) * 2007-04-09 2008-10-16 Purdue Pharma L.P. Benzenesulfonyl compounds and the use therof
WO2009040659A2 (en) * 2007-09-28 2009-04-02 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
US9963739B2 (en) 2010-05-21 2018-05-08 Hewlett-Packard Development Company, L.P. Polymerase chain reaction systems
US9090084B2 (en) 2010-05-21 2015-07-28 Hewlett-Packard Development Company, L.P. Fluid ejection device including recirculation system
JP2017535545A (ja) * 2014-11-21 2017-11-30 ラボラトリオス・デル・デエレ・エステベ・エセ・ア 疼痛に対する多様な活性を有するスピロ−イソキノリン−1,4’−ピペリジン化合物
CN107312056B (zh) * 2017-08-24 2019-10-25 广西师范学院 2-(3’-羟基-17’-孕甾烷基)-5-氟苯并咪唑的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908830A (en) 1996-10-31 1999-06-01 Merck & Co., Inc. Combination therapy for the treatment of diabetes and obesity
TWI279402B (en) * 1999-08-20 2007-04-21 Banyu Pharma Co Ltd Spiro compounds having NPY antagonistic activities and agents containing the same
CA2381111A1 (en) 1999-08-26 2001-03-01 Leah M. Giupponi Npy antagonists: spiroisoquinolinone derivatives
JP2003527444A (ja) 2000-03-23 2003-09-16 メルク エンド カムパニー インコーポレーテッド メラノコルチン受容体アゴニストとして作用するスピロピペリジン誘導体
EP1299362A4 (en) * 2000-07-05 2004-11-03 Synaptic Pharma Corp SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE

Also Published As

Publication number Publication date
CA2490531C (en) 2011-03-22
CN1665812A (zh) 2005-09-07
US7109207B2 (en) 2006-09-19
TW200401777A (en) 2004-02-01
ES2266861T3 (es) 2007-03-01
CA2490531A1 (en) 2004-01-08
JP2005535641A (ja) 2005-11-24
AR040344A1 (es) 2005-03-30
HK1071567A1 (en) 2005-07-22
EP1532147B1 (en) 2006-08-02
EP1532147A1 (en) 2005-05-25
DE60307289T2 (de) 2007-10-18
DE60307289D1 (de) 2006-09-14
MXPA05000185A (es) 2005-04-08
ATE334983T1 (de) 2006-08-15
JP4522853B2 (ja) 2010-08-11
AU2003258957A1 (en) 2004-01-19
WO2004002987A1 (en) 2004-01-08
US20040024002A1 (en) 2004-02-05
CN100374440C (zh) 2008-03-12

Similar Documents

Publication Publication Date Title
PE20040749A1 (es) Piperidinas espirosustituidas como antagonistas selectivos del receptor de la hormona concentradora de melanina
ES2524045T3 (es) Nuevas amidas y tioamidas heteroaromáticas como plaguicidas
PE20040960A1 (es) Derivados de piperazina acilados como agonistas del receptor de melanocortina-4
TW200734337A (en) Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists
ECSP056016A (es) Nuevos derivados de 2-piridinacarboxamida
ECSP055615A (es) Nuevos compuestos de amida de ácido carboxílico con efecto antagónico de la hcm, medicamentos que contienen estos compuestos y procedimientos para su preparación
PE20040687A1 (es) Quinolinas sustituidas como antagonistas del receptor ccr5
NO20050164L (no) Nye quinuklidin-amid-derivater
MY134017A (en) Mch antagonists and their use in the treatment of obesity
AR036939A1 (es) Antagonistas de la hormona de concentracion de melanina (mch) composiciones farmaceuticas, un proceso para su elaboracion y el uso de dichos compuestos, solos o en combinacion, para la elaboracion de un medicamento para el tratamiento de obesidad
NO20050749L (no) Nye alkyn-forbindelser med MCH-antagonistisk effekt og medikamenter inneholdende disse forbindelsene
TW200806629A (en) Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
NO20044826L (no) Pyrrolidinderivater
AR049652A1 (es) Sales cuaternarias antagonistas del receptor ccr2
ATE425166T1 (de) Amidderivate von 3-phenyldihydropyrimidoä4,5- düpyrimidinonen, deren herstellung und verwendung als pharmazeutische mittel
PE20081485A1 (es) Derivados de sulfonamida
DE60318219D1 (de) PYRIMIDINDERIVATE ALS MODULATOREN DER AKTIVITuT VON CHEMOKINREZEPTOREN
PE20050231A1 (es) Derivados de piperidinium y pirrolidinium como antagonistas del receptor muscarinico m3
RU2006112847A (ru) Производные тиазолопиридина в качестве лигандов аденозинового рецептора
PE20081876A1 (es) Aminoamidas como antagonistas de orexina
EA200701324A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
AR067412A1 (es) Moduladores de propiedades farmaceuticas de productos terapeuticos
US20030004189A1 (en) Pharmaceutical uses and synthesis of nicotinanilide-N-oxides
ATE432926T1 (de) Oxazolderivate als histamin-h3-rezeptor- wirkstoffe, deren herstellung und therapeutische verwendung
BRPI0518159A (pt) antagonistas de receptor de trombina

Legal Events

Date Code Title Description
FC Refusal